|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Division of Pulmonary and Critical Care Medicine, Rhode Island Hospital Brown University School of Medicine, Providence, RI.
Correspondence to: Mitchell M. Levy, MD, Division of Pulmonary and Critical Care Medicine, Rhode Island Hospital Brown University School of Medicine, 593 Eddy St, Main 7, Providence, RI 02903; e-mail: mitchell_levy{at}brown.edu
Complex physiologic interactions exist between oxygenation, hemoglobin, and cardiac output (Qt) in critically ill patients with respiratory failure. When any or all of these three critical factors fail, clinicians are challenged to support oxygen delivery (DO2) in order to avoid tissue hypoxia, end-organ damage, and high mortality rates. Many of the interventions performed to improve DO2, including mechanical ventilation, blood transfusions, fluid management, and invasive monitoring of cardiac function, are accompanied by serious risks that can exacerbate the pathology of DO2. This article provides an overview of oxygenation, hemoglobin, and Qt in patients with respiratory failure and highlights some of the current research that seeks safe and effective ways to improve DO2 in these patients.
Key Words: organ damage oxygen delivery oxygenation respiratory failure tissue hypoxia
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |